Redhill Biopharma Ltd at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Balaji Prasad. I lead the Specialty Pharma coverage for Barclays. Thank you for dialing in to the day 3 of Barclays Global Healthcare Conference.
And on the specialty pharma track of the conference today, I'm pleased to introduce the CEO of RedHill, Dror Ben-Asher today with us. The format is going to be a 10 to 12 minute presentation from Dror and then similar duration around -- for a fireside Q&A.
With this, Dror, thank you for taking your time today, and I invite you to take over.
Thank you. Thank you, Balaji, and thank you Barclays team for having us with you here. What we're going to do is a quick overview presentation, and then we'll take it from there to answer some questions.
For those of you who are not familiar with Red Hill. We are an asset listed company. We've been around for about 10 years, relatively on company and we are a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |